When does Sequana Medical (SEQUA.BR) report earnings?

Sequana Medical NV will report earnings on 25 Mar 2026. The pre-market move on 20 Mar 2026 reflects investor positioning five days before the release.

What is the current SEQUA.BR stock price and market cap?

SEQUA.BR trades at about **EUR 0.48** (exact tick **EUR 0.4785**) with a market cap near **EUR 35,661,616.00** and **74,527,934.00** shares outstanding.

What are the biggest risks to SEQUA.BR stock at earnings?

The main risks are short-term liquidity and the need for financing, weak revenue guidance, and slower commercial adoption of alfapump or DSR, which could lead to further dilution or downward price pressure.

What is Meyka AI’s view on SEQUA.BR stock?

Meyka AI rates SEQUA.BR **68.65 / 100 (Grade B, HOLD)**, reflecting mixed fundamentals, sector context and model forecasts. This is informational and not investment advice.

EU Stocks

SEQUA.BR Sequana Medical (Euronext) pre-market 20 Mar 2026: down 5.25%, watch cash

ByDanny Kontos March 20, 2026March 20, 2026

SEQUA.BR stock opened sharply lower in pre-market trade on 20 Mar 2026 after a weak session yesterday, trading at EUR 0.48 (previous close EUR 0.51, intraday low EUR 0.463). The main market move follows renewed investor focus on the company’s cash position and earnings due 25 Mar 2026. Sequana Medical NV (SEQUA.BR) reports results in five days, and investors will watch revenue trends, cash burn and guidance for the alfapump and DSR programs. Volume is elevated at 444,657 shares versus a 50-day average of 335,225 shares, signaling attention ahead of the call.